Biotherapy

, Volume 2, Issue 2, pp 149–158 | Cite as

Interferon-γ therapy in AIDS for mononuclear phagocyte activation

  • Henry W. Murray
Article

Key words

macrophage activation lymphokine interferon-γ CD4+ cell opportunistic infection intracellular killing 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Murray HW, Rubin BY, Masur H, Roberts RB. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 883–9.PubMedGoogle Scholar
  2. 2.
    Murray HW, Hillman JK, Rubin BY. Patients at risk for AIDS-related opportunistic infections: clinical manifestations and impaired gamma interferon production. N Engl J Med 1985; 313: 1504–10.PubMedGoogle Scholar
  3. 3.
    Murray HW, Scavuzzo DA, Kelly CD, Rubin BY, Roberts RB. T4+ cell production of interferon-gamma and the clinical spectrum of patients at risk for and with AIDS. Arch Intern Med 1988; 148: 1613–16.CrossRefPubMedGoogle Scholar
  4. 4.
    Epstein JS, Frederick WR, Rook AH. Selected defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis 1985; 152: 727–33.PubMedGoogle Scholar
  5. 5.
    Murray HW. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann Intern Med 1988; 108: 595–608.PubMedGoogle Scholar
  6. 6.
    Seligmann M, Pinching AJ, Rosen FS. Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update. Ann Intern Med 1987; 107: 234–42.PubMedGoogle Scholar
  7. 7.
    Kelly CD, Welte K, Murray HW. Antigen-induced human interferon-γ production: differential dependence on interleukin 2 and its receptor. J Immunol 1987; 139: 2325–8.PubMedGoogle Scholar
  8. 8.
    Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158: 670–89.CrossRefPubMedGoogle Scholar
  9. 9.
    Murray HW, Rubin BY, Rothermel CD. Killing of intracellularLeishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon7 is the activating lymphokine. J Clin Invest 1983; 72: 1506–10.PubMedGoogle Scholar
  10. 10.
    Rothermel CD, Rubin BY, Murray HW.γ-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellularChlamydia psittaci replication. J Immunol 1983; 131: 2542–4.PubMedGoogle Scholar
  11. 11.
    Koyanagi Y, O'Brien WA, Zhao JQ. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988; 241: 1673–5.PubMedGoogle Scholar
  12. 12.
    Squires KE, Schrieber RD, McElrath MJ, Murray HW. Role of endogenous interferon-γ in murine visceral leishmaniasis. Clin Res 1987; 35: 492A.Google Scholar
  13. 13.
    Murray HW, Godbold JH, Jurica KB, Roberts RB. Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: reappraisal of risk and predictive features. Am J Med 1989; 86: 533–538.CrossRefPubMedGoogle Scholar
  14. 14.
    Ho DD, Rota TR, Hirsch MS. Infection of monocytes/macrophages by human T lymphotropic virus type III. J Clin Invest 1986; 77: 1712–5.PubMedGoogle Scholar
  15. 15.
    Murray HW, Gellene RA, Libby DM, Rothermel CD, Rubin BY. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and gamma-interferon. J Immunol 1985; 135: 2374–7.PubMedGoogle Scholar
  16. 16.
    Lane HC, Sherwin SA, Masur H et al. A phase I trial of recombinant immune (γ) interferon in patients with the acquired immunodeficiency syndrome. Clin Res 1985; 33: 407A.Google Scholar
  17. 17.
    Pennington JE, Groopman JE, Small GJ, Laubenstein L, Finberg R. Effect of intravenous recombinantγ-interferon on the respiratory burst of blood monocytes from patients with AIDS. J Infect Dis 1986; 153: 609–12.PubMedGoogle Scholar
  18. 18.
    Miles SA, Martinez O, Sherwin S, Carden J, Mitsuyasu R. Phase I trial of recombinant interferon gamma in AIDS-related Kaposi's sarcoma. In: Proceedings of the 2nd International Conference on the Acquired Immunodeficiency Syndrome. Paris; 1986; 39: (abstract).Google Scholar
  19. 19.
    Parkin JM, Eales LJ, Moshtael O, Galazka AR, Pinching AJ. A preliminary report of the use of interferon-gamma in patients with the acquired immune deficiency syndrome. In: Staquet MJ, Hemmer R, Baert AE, eds. Clinical Aspects of AIDS and AIDS-Related Complex. Oxford: Oxford University Press; 1986: 167–74.Google Scholar
  20. 20.
    Murray HW, Scavuzzo D, Jacobs JL. In vitro and in vivo activation of human mononuclear phagocytes by gamma interferon: studies with normal and AIDS monocytes. J Immunol 1987; 138: 2457–62.PubMedGoogle Scholar
  21. 21.
    Fernandez-Guerrero ML, Aguado JM, Buzon L. Visceral leishmaniasis in immunocompromised hosts. Am J Med 1987; 83: 1098–1102.CrossRefPubMedGoogle Scholar
  22. 22.
    Nathan CG, Horowitz CR, De La Harpe J.et al. Administration of recombinant interferon-γ to cancer patients enhances monocyte secretion of hydrogen peroxide. Proc Natl Acad Sci USA 1985; 82: 8686–90.PubMedGoogle Scholar
  23. 23.
    Nathan CF, Kaplan G, Levis WR. Local and systemic effects of intradermal recombinant interferon-γ in patients with lepromatous leprosy. New Engl J Med 1986: 315: 6–15.PubMedGoogle Scholar
  24. 24.
    Panitch HS, Hirsch G, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987; 37: 1097–102.PubMedGoogle Scholar
  25. 25.
    Sechler JMG, Malech HL, White JCJ, Gallin JI. Recombinant human interferon-γ reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci 1988; 85: 4874–8.PubMedGoogle Scholar
  26. 26.
    Ezekowitz RAB, Dinaver MC, Jaffe JS, Orkin SH, Newburger PE. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon-gamma. N Engl J Med 1988; 319: 146–51.PubMedGoogle Scholar
  27. 27.
    Harms G, Chehade AK, Racz P. Effects of intradermal gamma interferon in cutaneous leishmaniasis. Lancet 1989; 1: 1287–92.CrossRefPubMedGoogle Scholar
  28. 28.
    Badaro R. Personal communication. 1989.Google Scholar
  29. 29.
    Murray HW, Scavuzzo D, Chapparas T, Roberts RB. T cell responses to mycobacterial antigen in AIDS patients with disseminatedMycobacterium avium-intracellulare. Chest 1988; 93: 922–6.PubMedGoogle Scholar
  30. 30.
    Squires KE, Murphy W, Madoff L, Murray HW. Interferon-γ treatment andMycobacterium avium-intracellulare infection. J Infect Dis 1989: 159: 599–600.PubMedGoogle Scholar
  31. 31.
    Murray HW, Welte K, Jacobs JL, Rubin BY, Mertelsmann R, Roberts RB. Production of an in vitro response to interleukin 2 in the acquired immunodeficiency syndrome. J Clin Invest 1985; 76: 1959–64.PubMedGoogle Scholar
  32. 32.
    Rinaldo C, Piazza P, Wang Y. HIV-1 specific production of IFN-γ and modulation by recombinant IL 2 during early HIV-1 infection. J Immunol 1988; 140: 3389–93.PubMedGoogle Scholar
  33. 33.
    Murray HW, DePamphilis J, Schooley RT, Hirsch MS. Circulating interferon-γ in AIDS patients treated with interleukin 2. N Engl J Med 1988; 318: 1538–9.PubMedGoogle Scholar
  34. 34.
    Hoffin JM, Remington JS. In vivo synergism of roxithromycin (RU 965) and interferon againstToxoplasma gondii. Antimicrob Agents Chemother 1987; 31: 346–8.PubMedGoogle Scholar
  35. 35.
    Murray HW, Berman JD, Wright SD. Immunochemotherapy for intracellularLeishmania donovani infection: interferon-γ plus pentavalent antibody. J Infect Dis 1988; 157: 973–8.PubMedGoogle Scholar
  36. 36.
    Murray HW. Survival of intracellular pathogens within human mononuclear phagocytes. Semin Hematol 1988; 25: 101–11.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1990

Authors and Affiliations

  • Henry W. Murray
    • 1
  1. 1.Division of Infectious DiseasesCornell University Medical College, The New York HospitalNew YorkUSA

Personalised recommendations